AzTrials
AzTrials

HypertensionTELENURSING-HTNCT07056530

Effectiveness of Telenursing on Self-Care and Blood Pressure Control in Adults With Hypertension

A study testing Telenursing Counseling in people with Hypertension and Nursing, run by Dursun Alper YILMAZ at 1 site in Turkey (Türkiye).

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

This quasi-experimental study aims to evaluate the effectiveness of a structured telenursing program in improving self-care practices and blood pressure control among adults with chronic hypertension in Türkiye. Read more about this study

Who is it for?
Ages 30 to 75 years
Conditions the study is for
Hypertension, Nursing, Telenursing
What is being tested?
Telenursing Counseling
Could I receive a placebo?
No, everyone receives an active treatment
How many people
151 participants
Where
1 siteTurkey (Türkiye)
Study dates
22 Mar 2024to 1 Jun 2025
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 30 to 75 years
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Who may be able to join

  • Diagnosed with chronic hypertension for at least 1 year.
  • Aged between 30 and 75 years.
  • Able to communicate via telephone.
  • Provided informed consent to participate.

Who cannot join

  • Diagnosed with severe comorbid conditions (e.g., advanced heart failure, cancer).
  • Cognitive impairment that prevents communication.
  • Hearing impairment that prevents phone counseling.
  • Participation in another hypertension intervention program within the last 6 months.

Trial locations and contacts

1 site in 1 country.

Turkey (Türkiye)1 site
  • Ağrı İbrahim Çeçen University

    Ağrı, 0400

Other trials in Turkey (Türkiye)

About this study

Official title: Effectiveness of Telenursing in Improving Self-Care and Blood Pressure Control Among Adults With Chronic Hypertension: A Quasi-Experimental Study in Türkiye

This quasi-experimental study aims to evaluate the effectiveness of a structured telenursing program in improving self-care practices and blood pressure control among adults with chronic hypertension in Türkiye. Participants received weekly telephone-based nursing counseling for eight weeks, focusing on medication adherence, healthy nutrition, physical activity, stress management, and regular self-monitoring. The study compares changes in blood pressure and self-care scores between the intervention and control groups.

Read the detailed description

Hypertension remains one of the most prevalent chronic diseases worldwide, significantly contributing to cardiovascular morbidity and mortality. Despite advances in pharmacological treatment, non-pharmacological support and patient self-care play a crucial role in achieving optimal blood pressure control. This study was designed as a quasi-experimental pretest-posttest controlled trial to test whether a structured telenursing intervention improves self-care behaviors and blood pressure outcomes in adults with chronic hypertension.

The study was conducted at Ağrı Training and Research Hospital in Türkiye between March 2024 and March 2025. A total of 151 participants aged 30-75 years were recruited and assigned to an intervention group or a control group. The intervention group received weekly telephone-based nursing counseling sessions delivered by trained nurses for eight consecutive weeks. Counseling covered key self-care topics including medication adherence, dietary modifications, physical activity, stress reduction, and blood pressure self-monitoring. The control group received usual care.

Primary outcomes included changes in systolic blood pressure and mean arterial pressure. Secondary outcomes included changes in self-efficacy and self-care practices measured by the Hypertension Self-Care Profile (HTN-SCP). Ethical approval was obtained from Ağrı İbrahim Çeçen University Scientific Research Ethics Committee (Approval No: E102912). Official permission for implementation was provided by the Ağrı Provincial Directorate of Health (Approval No: E24156). The study was supported by TÜBİTAK (Project No: 919B012319310). Findings from this study aim to support the use of telenursing as a cost-effective digital health strategy for chronic disease management in resource-limited settings.

Being tested
Telenursing Counseling
Medical subject headings
Hypertension

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Telenursing CounselingBehavioural

    Also called Weekly Remote Nursing Counseling

    Structured weekly phone-based counseling sessions delivered by a trained nurse for 8 weeks, focusing on medication adherence, healthy lifestyle behaviors, stress management, and self-monitoring of blood pressure.

Study groups in NCT07056530
Study groupRoleWhat they receive
Intervention GroupExperimentalParticipants in this group received a structured telenursing program consisting of weekly phone-based counseling sessions for 8 weeks, focusing on medication adherence, healthy nutrition, physical activity, stress management, and blood pressure self-monitoring.
Receives: Behavioral: Telenursing Counseling
Control GroupNo interventionParticipants in this group received usual care provided by the hospital without any additional telenursing counseling.

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Change in Systolic Blood Pressure (SBP)

    Difference in mean systolic blood pressure from baseline to 8 weeks after the intervention.

    Measured: Baseline and 8 weeks post-intervention

Secondary outcomes (1)
  1. Change in Hypertension Self-Care Profile (HTN-SCP) Score

    Difference in mean HTN-SCP score from baseline to 8 weeks post-intervention to assess improvement in self-care behaviors.

    Measured: Baseline and 8 weeks post-intervention

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted9 Jul 2025
  2. Study start22 Mar 2024
  3. Primary completion22 Mar 2025
  4. Study completion1 Jun 2025

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Health services research
Allocation
Non-randomised
Intervention model
Parallel groups
Model description
Quasi-experimental, non-randomized, parallel design comparing an 8-week telenursing intervention group to a control group.
Masking
None (open label)
Enrolment
151 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT07056530
Sponsor's protocol ID
TELENURSING-HTN-2025-AICU
Other IDs
919B012319310
Acronym
TELENURSING-HT
Status last verified
Jun 2025
First submitted
30 Jun 2025
Last updated
9 Jul 2025
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No: Individual participant data (IPD) will not be shared because the dataset includes personal health information and no additional consent for public sharing was obtained. Only summary results will be published in scientific journals.

Questions about this trial

What is this clinical trial studying?

A study testing Telenursing Counseling in people with Hypertension and Nursing, run by Dursun Alper YILMAZ at 1 site in Turkey (Türkiye).

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 4 inclusion and 4 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 9 Jul 2025. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Turkey (Türkiye). Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Change in Systolic Blood Pressure (SBP) (time frame: Baseline and 8 weeks post-intervention). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 9 Jul 2025.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in